Barone Francesca
Officer at CADL
- Sold, on record
- $995k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jun 29, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CADLCandel Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice CADLNoticeJan 8, 2025 2025
Filed to sell 13,440 shares ($112k)
Barone Francesca, Officer
No 10b5-1 plan1x usual sizeFiling
- 2 Form 4 sale CADLNo planJan 8, 2025 same day
Sold 13,673 shares at $8.22 ($112k)
Barone Francesca, Chief Scientific Officer
No 10b5-1 planSold 9.9% of holdings ($1.1M position)124,207 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice CADLNoticeJan 15, 2025 +7 days
Filed to sell 12,452 shares ($98k)
Barone Francesca, Officer
No 10b5-1 plan0.9x usual sizeFiling
- 4 Form 4 sale CADLNo planJan 15, 2025 same day
Sold 13,534 shares at $7.23 ($98k)
Barone Francesca, Chief Scientific Officer
No 10b5-1 planSold 10.9% of holdings ($898k position)110,673 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice CADLNoticeMar 18, 2025 +62 days
Filed to sell 32,146 shares ($284k)
Barone Francesca, Officer
10b5-1 plan2.4x usual sizeFiling
- 6 Form 4 sale CADLRoutineMar 18, 2025 same day
Sold 32,146 shares at $8.76 ($282k)
Barone Francesca, Chief Scientific Officer
10b5-1 planSold 25% of holdings ($1.1M position)96,527 shares left2.4x usual sizeFollows a Form 144Filing
- 7 Form 144 notice CADLNoticeJun 29, 2026 +468 days
Filed to sell 23,447 shares ($230k)
Barone Francesca, Officer
10b5-1 plan1.7x usual sizeFiling
- 8 Form 4 sale CADLRoutineJun 29, 2026 same day
Sold 23,447 shares at $10.06 ($236k)
Barone Francesca, Chief Scientific Officer
10b5-1 planSold 23.3% of holdings ($1M position)77,362 shares left1.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jul 1, 2026 | CADL | Chief Scientific Officer | Form 4 sale | 23,447 | $236k | 23.3% | Routine | SEC |
| Jun 29, 2026 | Jun 29, 2026 | CADL | Officer | Form 144 notice | 23,447 | $230k | Notice | SEC | |
| Mar 18, 2025 | Mar 20, 2025 | CADL | Chief Scientific Officer | Form 4 sale | 32,146 | $282k | 25.0% | Routine | SEC |
| Mar 18, 2025 | Mar 18, 2025 | CADL | Officer | Form 144 notice | 32,146 | $284k | Notice | SEC | |
| Jan 15, 2025 | Jan 17, 2025 | CADL | Chief Scientific Officer | Form 4 sale | 13,534 | $98k | 10.9% | No plan | SEC |
| Jan 15, 2025 | Jan 15, 2025 | CADL | Officer | Form 144 notice | 12,452 | $98k | Notice | SEC | |
| Jan 8, 2025 | Jan 10, 2025 | CADL | Chief Scientific Officer | Form 4 sale | 13,673 | $112k | 9.9% | No plan | SEC |
| Jan 8, 2025 | Jan 8, 2025 | CADL | Officer | Form 144 notice | 13,440 | $112k | Notice | SEC | |
| Nov 29, 2024 | Dec 3, 2024 | CADL | Chief Scientific Officer | Form 4 sale | 22,081 | $101k | 13.8% | No plan | SEC |
| Nov 29, 2024 | Nov 29, 2024 | CADL | Officer | Form 144 notice | 20,085 | $99k | Notice | SEC | |
| Jul 17, 2024 | Jul 19, 2024 | CADL | Chief Scientific Officer | Form 4 sale | 14,051 | $91k | 8.1% | No plan | SEC |
| Jul 17, 2024 | Jul 17, 2024 | CADL | Officer | Form 144 notice | 12,455 | $91k | Notice | SEC | |
| Jul 11, 2024 | Jul 15, 2024 | CADL | Chief Scientific Officer | Form 4 sale | 12,645 | $75k | 6.8% | No plan | SEC |
| Jul 11, 2024 | Jul 11, 2024 | CADL | Officer | Form 144 notice | 12,443 | $74k | Notice | SEC |